Angiotensin II Type 1 (AT1) Receptor Deficiency Halts the Progression of Age-Related Atherosclerosis in Hypercholesterolemia: Molecular Link between the AT1 Receptor and Hypercholesterolemia

Wassmann S, Nickenig G : Pathophysiological regulation of the AT1-receptor and implications for vascular disease. J Hypertens Suppl 2006; 24 : S15–S21. Article CAS Google Scholar Nickenig G, Harrison DG : The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: Oxidative stress and atherogenesis. Circulation 2002; 105 : 393–396. Article CAS Google Scholar Nickenig G, Harrison DG : The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part II: AT1 receptor regulation. Circulation 2002; 105 : 530–536. Article CAS Google Scholar Daugherty A, Rateri DL, Lu H, et al : Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 2004; 110 : 3849–3857. Article CAS Google Scholar Tunon J, Martin-Ventura JL, Blanco-Colio LM, et al : Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vasc Health Risk Manag 2007; 3 : 521–526. PubMed PubMed Central Google Scholar Keidar S, Attias J, Heinrich R, et al : Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis. Atherosclerosis 1999; 146 : 249–257. Article CAS Google Scholar Warnholtz A, Nickenig G, Schulz E, et al : Increased NADH-oxidase–mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99 : 2027–2033. Article CAS Google Scholar Nickenig G, Sachinidis A, Michaelsen F, et al : Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 1997; 95 : 473–478. Article CAS Google Scholar Solini A, Santini E, Ferrannini E : Enhanced angiotensin II–mediated effects in fibroblasts of patients with familial hypercholesterolemia. J Hypertens 2005; 23 : 367–374. Article CAS Google Scholar Takai S, Jin D, Sakaguchi M, et al : Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model. Hypertens Res 2004; 27 : 517–522. Article CAS Google Scholar Mueller CF, Nickenig G : Angiotensin II: one driving force behind atherogenesis. Hypertension 2008; 51 : 175–176. Article CAS Google Scholar Wassmann S, Czech T, van Eickels M, et al : Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110 : 3062–3067. Article CAS Google Scholar Diz DI : Lewis K . Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension 2008; 52 : 37–43. Article CAS Google Scholar Miyazaki M, Takai S : Antiatherosclerotic effect of alacepril, alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet. Hypertens Res 1999; 22 : 49–54. Article CAS Google Scholar Urata H : Chymase and matrix metalloproteinase. Hypertens Res 2007; 30 : 3–4. Article Google Scholar Eto H, Miyata M, Shirasawa T, et al : The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis. Hypertens Res 2008; 31 : 1631–1642. Article CAS Google Scholar Vaughan DE : AT1 receptor blockade and atherosclerosis: hopeful insights into vascular protection. Circulation 2000; 101 : 1496–1497. Article CAS Google Scholar Weiss D, Kools JJ, Taylor WR : Angiotensin II–induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001; 103 : 448–454. Article CAS Google Scholar Strawn WB, Chappell MC, Dean RH, et al : Inhibition of early atherogenesis by losartan in monkeys with dietinduced hypercholesterolemia. Circulation 2000; 101 : 1586–1593. Article CAS Google Scholar Wassmann S, Hilgers S, Laufs U, et al : Angiotensin II type 1 receptor antagonism improves hypercholesterolemia associated endothelial dysfunction. Arterioscler Thromb Vasc Biol 2002; 22 : 1208–1212. Article CAS Google Scholar Fujita M, Yamazaki T, Hayashi D, et al : Comparison of cardiovascular events in patients with angiographically documented coronary narrowing with combined reninangiotensin system inhibitor plus statin versus renin-angiotensin system inhibitor alone versus statin alone (from the Japanese Coronary Artery Disease Study). Am J Cardiol 2007; 100 : 1750–1753. Article CAS Google Scholar Download references